Colgate-Palmolive Co. 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Co. for the period ended June 30, 1995. The company operates in oral, personal, and household care, as well as specialty marketing (including Hill's Pet Nutrition). A significant event during this period was the acquisition of the Kolynos oral care business on January 10, 1995, for $1,040 million in cash.
Key Financial Metrics
| Metric | Q2 1995 | Q2 1994 | 6 Months 1995 | 6 Months 1994 |
|---|---|---|---|---|
| Net Sales ($ millions) | $2,090.7 | $1,891.1 | $4,071.0 | $3,661.1 |
| Gross Profit ($ millions) | $980.1 | $902.7 | $1,950.0 | $1,764.8 |
| Gross Margin (%) | 46.9% | 47.7% | 47.9% | 48.2% |
| Net Income ($ millions) | $143.2 | $142.5 | $299.7 | $292.1 |
| Diluted EPS ($) | $0.88 | $0.87 | $1.85 | $1.78 |
| Operating Cash Flow ($ millions) | N/A | N/A | $218.8 | $271.0 |
| Total Debt ($ millions) | $3,325.2 | N/A | $3,325.2 | N/A |
| Cash & Equivalents ($ millions) | $165.4 | N/A | $165.4 | N/A |
Note: Total Debt includes Notes and loans payable ($320.6M) and Long-term debt ($2,965.1M) as of June 30, 1995.
Material Changes vs. Prior Period
- Sales Growth: Worldwide sales increased 11% in Q2 1995 and 11% for the first half of 1995 compared to the prior year. This includes a 6% unit volume gain in Q2, driven significantly by the Kolynos acquisition.
- Margin Compression: Gross profit margins declined to 46.9% in Q2 (from 47.7%) and 47.9% for the first half (from 48.2%), primarily due to increased raw material and packaging costs.
- Interest Expense: Net interest expense surged to $48.7 million in Q2 (from $15.8 million) and $92.7 million for the first half (from $36.4 million), reflecting debt incurred to finance the Kolynos acquisition.
- Regional Performance: Latin America sales grew 19% in Q2 (23% volume), though Mexico experienced a 9% volume decline due to peso devaluation. Europe sales grew 8% despite a 4% volume decline, aided by currency gains.
- Divestitures: Specialty Marketing sales declined 13% in Q2 due to the prior year's sale of Princess House and VCA.
Guidance, Outlook, and Risks
- Acquisition Integration: Management expects the Kolynos acquisition to be dilutive to earnings per share in the short term (approx. $0.06 in Q2 and $0.12 for the first half) but anticipates future synergies will offset this impact.
- Regulatory Risks: The Kolynos acquisition is currently under review by antitrust regulatory authorities in Brazil.
- Economic Risks: Reduced profits in Mexico were attributed to the current slowdown in the Mexican economy. Economic softness also impacted sales in Italy and Germany.
- Liquidity: Working capital increased to $804.8 million. Commercial paper outstanding was $1,474.6 million, classified as long-term due to the intent to refinance.
Investor Verification Checklist
- Verify the status of the antitrust review for the Kolynos acquisition in Brazil.
- Monitor the integration progress of Kolynos to assess the timeline for realizing anticipated synergies and offsetting dilution.
- Track raw material and packaging cost trends to determine if gross margin compression is temporary or structural.
- Assess the impact of currency fluctuations, particularly the Mexican peso, on future Latin American sales and earnings.
- Review the company's debt refinancing strategy given the significant increase in interest expense and total debt load.